Related Experiment Video
Updated: Jun 4, 2026

Halogenated Agent Delivery in Porcine Model of Acute Respiratory Distress Syndrome via an Intensive Care Unit Type Device
Published on: September 24, 2020
Delirium and sedation in the ICU
1Neuroscience Intensive Care Unit, Departments of Neurosurgery and Neurology, Mount Sinai School of Medicine, One Gustave Levy Place, Box 1136, New York, NY 10029, USA. Jennifer.Frontera@mountsinai.org
Reducing intensive care unit (ICU) sedation aids delirium diagnosis and management. This approach can shorten mechanical ventilation, reduce hospital stay, and improve long-term survival rates.
Area of Science:
- Critical Care Medicine
- Neuroscience
- Geriatrics
Background:
- Delirium, characterized by fluctuating attention, is linked to higher ICU mortality and worse cognitive function.
- Sedation in the ICU can exacerbate or contribute to the development of delirium.
- Both general and neurocritical care populations are affected by these adverse outcomes.
Purpose of the Study:
- To highlight the impact of sedation on delirium in ICU settings.
- To emphasize the benefits of limiting sedation for delirium diagnosis and patient outcomes.
- To underscore the importance of identifying delirium's root causes for effective treatment.
Main Methods:
- Review of existing literature on delirium, sedation, and ICU outcomes.
- Analysis of the relationship between sedation practices and delirium incidence.
- Examination of the consequences of delirium on mortality and cognitive function.
Main Results:
- Limiting ICU sedation facilitates the identification of neurological insults.
- Reduced sedation is associated with decreased mechanical ventilation duration.
- Shorter ICU length of stay and improved 1-year mortality rates are observed with limited sedation.
Conclusions:
- Minimizing sedation in ICUs is crucial for diagnosing and managing delirium.
- Early identification of delirium's etiology is key for developing targeted therapies.
- Optimizing sedation strategies can significantly improve patient outcomes in critical care.
More Related Videos
04:56In Vitro Method to Control Concentrations of Halogenated Gases in Cultured Alveolar Epithelial Cells
Published on: October 23, 2018
06:04Objective Nociceptive Assessment in Ventilated ICU Patients: A Feasibility Study Using Pupillometry and the Nociceptive Flexion Reflex
Published on: July 4, 2018
Related Concept Videos
Stages of General Anesthesia
Parenteral Anesthetics: Overview
Sedatives and Hypnotics: Overview
Sedative-hypnotics are categorized into barbiturates, benzodiazepines (BZDs), and non-benzodiazepines or Z-drugs. These drugs work by suppressing central nervous system activity, and this suppression is dose-dependent. Older sedative medications, like barbiturates, follow a linear curve in...
Sedatives and Hypnotics Drugs: Miscellaneous Agents
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
CNS Depressants: Barbiturates and Benzodiazepines
Sedatives and Hypnotics Drugs: Benzodiazepines
Benzodiazepines work by enhancing the effects of the inhibitory neurotransmitter GABA. They bind to the GABAA receptor, increasing its affinity for GABA, which opens chloride...